Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium phosphate tribasic dodecahydrate is a small molecule inorganic salt used primarily as a pharmaceutical excipient and buffering agent. With the chemical formula Na3PO4·12H2O, it is employed in drug formulations to maintain a stable pH, which is critical for the stability, solubility, and efficacy of active pharmaceutical ingredients. Although it has been utilized in the pharmaceutical industry since 1921 and holds US Approved Rx status as an inactive ingredient, it is not typically used as a standalone therapeutic agent for specific diseases. It is also a common reagent in biochemical research and laboratory applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium phosphate tribasic dodecahydrate.